Have the giants gotten too big for anyone’s good? This week, the top 10 companies in the S&P 500 made up more than 37.5% of the index’s total market value. Many market commentators will tell ...

Shares of Tesla Inc. fell again on Monday, as a negative turn in how Chief Executive Elon Musk is being viewed by consumers is fueling concern that sales will take a hit. There’s also a growing ...

Malnutrition, I saw on this trip, is a vast and under-addressed problem — but also one that we can solve if we commit to it. Nicholas Kristof became a columnist for The Times Opinion desk in ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a price target of $5.85. The company’s shares closed ...

In the latest quarter, 11 analysts provided ratings for Nevro (NYSE:NVRO), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...